Hongxiao Yang

Hongxiao Yang

Auto-generated profile, based on publicly available information

Hongxiao Yang

Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Harbin, Heilongjiang 150001, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2016 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
YGYunan Gao
Yunan Gao
HYHongxiao Yang
Hongxiao Yang
YFYanbin Fan
Yanbin Fan
LLLin Li
Lin Li
JFJiahui Fang
Jiahui Fang
WYWei Yang
Wei Yang
Doxorubicin (DOX) remains the most effective anticancer agent which is widely used in several adult and pediatric cancers, but its application is limited for its cardiotoxicity and hepatotoxicity. Hydrogen, as a selective antioxidant, is a promising potential therapeutic option for many diseases. In this study, we found that intraperitoneal injection of hydrogen-rich saline (H2 saline) ameliorated the mortality, cardiac dysfunction, and histopathological changes caused by DOX in rats. Meanwhile, serum brain natriuretic peptide (BNP), aspartate transaminase (AST), alanine transaminase (ALT), albumin (ALB), tissue reactive oxygen species (ROS), and malondialdehyde (MDA) levels were also attenuated after H2 saline treatment. What is more, we further demonstrated that H2 saline treatment could inhibit cardiac and hepatic inflammation and apoptosis relative proteins expressions by western blotting test. In conclusion, our results revealed a protective effect of H2 saline on DOX-induced cardiotoxicity and hepatotoxicity in rats by inhibiting inflammation and apoptosis.

1 July 2021 in Disease Markers
Verified
Journal Article
Open access
PDF file
HYHongxiao Yang
Hongxiao Yang
LSLina Shan
Lina Shan
YGYunan Gao
Yunan Gao
LLLin Li
Lin Li
GXGuifen Xu
Guifen Xu
WYWei Yang
Wei Yang
Heart failure (HF) is the typical terminal stage of cardiac diseases involving inflammatory states. The function of microRNAs (miRNAs) in the progress of HF remains poorly understood. In this study, real-time PCR results showed a decreased expression of miRNA-181b (miR-181b) in HF patients compared with healthy individuals. Besides, miR-181b expressions were negatively correlated with hypersensitive C-reactive protein (hsCRP) levels in the serum of HF patients. Receiver operator characteristic (ROC) curve analysis showed that miR-181b was a diagnostic predictor of HF, and the area under the curve was 0.970 (DCM-induced HF group) and 0.962 (ICM-induced HF group). Strikingly, in HF rats induced by isoproterenol (ISO), the expression of miR-181b of heart tissue was suppressed before tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) increase, as revealed by western blot and real-time PCR. Besides, the overexpression of miR-181b also decreased the expression of TNF-α, IL-1β, and IL-6 in lipopolysaccharide- (LPS-) induced neonatal cardiomyocytes. In conclusion, our results revealed that miR-181b might be a potential biomarker for HF and provided a novel target for anti-inflammatory therapy.

17 October 2017 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
YGYunan Gao
Yunan Gao
HYHongxiao Yang
Hongxiao Yang
YFYanbin Fan
Yanbin Fan
LLLin Li
Lin Li
JFJiahui Fang
Jiahui Fang
WYWei Yang
Wei Yang
[This corrects the article DOI: 10.1155/2016/1320365.].